ABIO Share Price

Open 2.70 Change Price %
High 2.75 1 Day 0.15 5.88
Low 2.65 1 Week 0.10 3.85
Close 2.70 1 Month 0.15 5.88
Volume 48771 1 Year -1.32 -32.84
52 Week High 4.22
52 Week Low 2.15
ABIO Important Levels
Resistance 2 2.79
Resistance 1 2.75
Pivot 2.70
Support 1 2.65
Support 2 2.61
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
SIRI 5.02 -1.76%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
INTC 37.43 1.35%
More..
NASDAQ USA Top Gainers Stocks
SPIR 0.02 100.00%
LOCM 0.09 50.00%
IFON 0.63 34.04%
WRES 0.09 28.57%
SMSI 1.13 28.41%
EXAS 30.14 26.64%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
OPHC 2.80 21.21%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LLEN 0.01 -50.00%
PGRX 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
SNCR 13.29 -46.02%
DVOX 0.05 -44.44%
More..

ARCA biopharma, Inc. (NASDAQ: ABIO)

ABIO Technical Analysis 2
As on 27th Apr 2017 ABIO Share Price closed @ 2.70 and we RECOMMEND Sell for LONG-TERM with Stoploss of 2.71 & Strong Buy for SHORT-TERM with Stoploss of 2.51 we also expect STOCK to react on Following IMPORTANT LEVELS.
ABIO Target for April
1st Target up-side 2.74
2nd Target up-side 2.87
3rd Target up-side 3.01
1st Target down-side 2.36
2nd Target down-side 2.23
3rd Target down-side 2.09
ABIO Other Details
Segment EQ
Market Capital 4122726.75
Sector Healthcare
Industry Biotechnology
Offical website http://www.arcabiopharma.com
ABIO Address
ABIO
11080 CirclePoint Road
Suite 140
Westminster, CO 80020
United States
Phone: 720-940-2200
ABIO Latest News
Interactive Technical Analysis Chart ARCA biopharma, Inc. ( ABIO NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on ARCA biopharma, Inc.
ABIO Business Profile
ARCA biopharma, Inc. (ARCA), incorporated in 1992, is a bio-pharmaceutical company. The Company’s principal focus is developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA’s lead product candidate is Gencaro TM (bucindolol hydrochloride), a pharmacologically beta-blocker and mild vasodilator being developed for the treatment of chronic heart failure (HF). ARCA biopharma, Inc. is a Colorado-based biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases.The Company has collaborated with LabCorp to develop the Gencaro Test, a companion test for the genetic markers that may predict clinical response to Gencaro. ARCA’s product candidate is Gencaro (bucindolol hydrochloride), a pharmacologically beta-blocker and mild vasodilator being developed for the treatment of chronic heart failure (HF). Gencaro (bucindolol hydrochloride) is a pharmacologically beta-blocker and mild vasodilator being developed for the treatment of AF. Gencaro is considered part of the beta-blocker class of compounds because of its property of blocking both beta-1 and beta-2 receptors in the cardiac nervous system. The Company Address is Suite 200, 8001 Arista Place, BROOMFIELD CO 80021.